Tarsus Pharmaceuticals, Inc. (TARS)
61.35
-0.20
(-0.32%)
USD |
NASDAQ |
Jun 10, 16:00
61.35
0.00 (0.00%)
After-Hours: 20:00
Tarsus Pharmaceuticals 1 Year Total Returns (Daily) : 42.77% for June 9, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| June 09, 2026 | 42.77% |
| June 08, 2026 | 35.79% |
| June 05, 2026 | 34.48% |
| June 04, 2026 | 41.48% |
| June 03, 2026 | 33.82% |
| June 02, 2026 | 30.92% |
| June 01, 2026 | 37.21% |
| May 29, 2026 | 36.74% |
| May 28, 2026 | 41.59% |
| May 27, 2026 | 43.41% |
| May 26, 2026 | 42.30% |
| May 22, 2026 | 44.89% |
| May 21, 2026 | 46.98% |
| May 20, 2026 | 44.36% |
| May 19, 2026 | 36.17% |
| May 18, 2026 | 43.75% |
| May 15, 2026 | 43.63% |
| May 14, 2026 | 51.93% |
| May 13, 2026 | 55.96% |
| May 12, 2026 | 35.36% |
| May 11, 2026 | 33.27% |
| May 08, 2026 | 29.85% |
| May 07, 2026 | 35.08% |
| May 06, 2026 | 39.42% |
| May 05, 2026 | 35.50% |
| Date | Value |
|---|---|
| May 04, 2026 | 36.34% |
| May 01, 2026 | 26.48% |
| April 30, 2026 | 22.54% |
| April 29, 2026 | 19.19% |
| April 28, 2026 | 24.88% |
| April 27, 2026 | 21.86% |
| April 24, 2026 | 22.97% |
| April 23, 2026 | 21.94% |
| April 22, 2026 | 28.40% |
| April 21, 2026 | 32.98% |
| April 20, 2026 | 33.95% |
| April 17, 2026 | 36.53% |
| April 16, 2026 | 37.11% |
| April 15, 2026 | 46.17% |
| April 14, 2026 | 51.50% |
| April 13, 2026 | 56.47% |
| April 10, 2026 | 64.46% |
| April 09, 2026 | 57.89% |
| April 08, 2026 | 61.08% |
| April 07, 2026 | 44.79% |
| April 06, 2026 | 49.28% |
| April 02, 2026 | 36.18% |
| April 01, 2026 | 43.54% |
| March 31, 2026 | 36.56% |
| March 30, 2026 | 29.34% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Structure Therapeutics, Inc. | 101.1% |
| Eton Pharmaceuticals, Inc. | 92.62% |
| Alumis, Inc. | 483.4% |
| Veradermics, Inc. | -- |
| ANI Pharmaceuticals, Inc. | 28.52% |